A small group of melanoma patients may need far less immunotherapy with surgery, study suggests
Interim results from a clinical trial conducted by researchers in the Netherlands and Australia suggest that some melanoma patients may need far less immunotherapy than …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
